In the developing mammalian tooth, the cranial neural crest derived dental mesenchyme consists of the dental papilla and dental follicle. The dental papilla gives rise to odontoblasts and dental pulp and the dental follicle gives rise to the periodontium, including the osteoblasts that contribute to the alveolar process. The alveolar process is a specialized intramembranous bone that forms the primary support structure for the dentition. The Msx1 gene controls many aspects of craniofacial development, as evidenced by craniofacial abnormalities seen in Msx1 2/2 mice, including the arrest of tooth development and the absence of the alveolar bone. Previous studies demonstrated that ectopic expression of Bmp4, a downstream target of Msx1, in the Msx1 2/2 dental mesenchyme rescued alveolar bone formation. Here we confirm an early requirement of BMP activity for alveolar bone formation. We show that the expression of Cbfa1 and Dlx5, two genes encode transcription factors that are critical for bone differentiation, overlaps with that of Msx1 and Bmp4 in the developing tooth and alveolar process. We have demonstrated that Dlx5 and Cbfa1 expression is down-regulated in Msx1 2/2 dental mesenchyme and that Msx1 and Bmp4 expression are unaltered in Cbfa1 2/2 mice. These data place Dlx5 and Cbfa1 downstream from the Msx1/Bmp4 in the genetic pathway that regulates tooth development. Ectopic expression of Bmp4 in Msx1 mutants restores the expression of Dlx5, but not Cbfa1, in the dental mesenchyme, and rescues the expression of both Dlx5 and Cbfa1 in the developing alveolar bone. Therefore, the early expression of Cfba1 in the dental mesenchyme appears dispensable for the development of the alveolar bone. Taken together with in vitro gene induction studies, our results demonstrate that BMP4 controls Dlx5 expression in dental mesenchyme, and functions upstream to both Dlx5 and Cbfa1 to regulate alveolar bone formation during tooth development. q
Introduction
In mice, the bone tissue of the mandibular and maxillary alveolar processes is formed via intramembranous ossification, in which bone growth begins with the condensation of mesenchymal cells that expand and form a membranous structure, and then differentiate directly into osteoblasts (Saffar et al., 1997; Zernik et al., 1997) . The alveolar process houses and supports the dentition and is a toothdependent bony structure. Tooth development in mice initiates as a local thickening of oral epithelium in the potential tooth forming regions at embryonic day 11 (E11). Subsequently this thickened epithelium grows into the underlying neural crest-derived mesenchyme of the first branchial arch and forms a tooth bud between E12 and E13. The invaginated epithelium meanwhile stimulates proliferation and condensation of the subjacent mesenchyme which consists of the dental papilla that is odontogenic and dental follicle that is preosteogenic (Cho and Garant, 2000) . Subsequently, the dental papilla gives rise to the odontoblasts and the dental pulp of the tooth. The dental follicle, which appears as a well-defined band of cells juxtaposed to the dental papilla, gives rise to the periodontium including the cementum, periodontal ligament, and alveolar processes (Cho and Garant, 2000; Sodek and Mckee, 2000) . The developmental potential of the dental follicle was determined by fate tracing studies and tissue recombination experiments (Ten Case et al., 1971; Ten Case and Mills, 1972; Palmer and Lumsden, 1987) . The anatomical and cellular structures of the alveolar bone have been described in detail previously (Saffar et al., 1997; Sodek and Mckee, 2000) . However, the molecular mechanisms of induction and differentiation of osteoblasts in the alveolar bone during tooth development have remained elusive.
The Cbfa1 protein was first identified as the nuclear protein that bind to an osteoblast specific cis-acting element that activates the expression of Osteocalcin, an osteoblastspecific gene (Ducy, 2000, for review) . The expression of Cbfa1 in the developing mouse embryo is largely confined to the areas of mesenchymal condensation that form future bone structures (Ducy et al., 1997; Otto et al., 1997) . Null mutation of Cbfa1 results in a complete lack of osteoblast differentiation and bone formation, which is probably due to a maturational arrest of osteoblasts (Ducy et al., 1997; Komori et al., 1997; Otto et al., 1997) . These studies indicate that Cbfa1 is a key regulator of osteoblast differentiation and function (Karsenty, 2000) . In addition, Cbfa1 is also required for normal tooth development (D'Souza et al., 1999) . Cbfa1 is initially expressed in the dental mesenchyme at the E12.5 bud stage, and expression is down-regulated in the dental papilla at the early bell stage. The expression of Cbfa1 in both the dental papilla and dental follicle suggests a potential involvement of this gene in the differentiation of odontoblasts and periodontal osteoblasts (D'Souza et al., 1999; Jiang et al., 1999) . Mice deficient in Cbfa1 indeed exhibit an arrest of molar tooth development at the early cap stage, suggesting a requirement for Cbfa1 in the progression of tooth development from the cap stage to the bell stage (D'Souza et al., 1999) .
In mammals, the Dlx family of homeobox genes has been shown to play critical roles in many embryonic developmental processes, including neurogenesis and skeletogenesis (Panganiban and Rubenstein, 2002) . Dlx5 and Dlx6 are uniquely expressed in all skeletal elements. Dlx5 is expressed in developing and differentiating cartilage, bone, and tooth, implicating a general role for Dlx5 in regulating the formation of these hard tissues (Weiss et al., 1994 (Weiss et al., , 1995 Ferrari et al., 1995; Ryoo et al., 1997; Newberry et al., 1998) . Several lines of evidence suggest that the Dlx5 gene function critically in osteogenic development. Dlx5 is expressed in a stage specific manner in differentiating osteoblasts in vitro, probably by regulating the expression of Osteocalcin and the collagen 1A1 and bone sialoprotein genes (Dodig et al., 1996; Ryoo et al., 1997; Newberry et al., 1998; Acampora et al., 1999; Benson et al., 2000) . Indeed, the lack of a functional Dlx5 protein in mice results in dysmorphogenesis in almost all cranial bones and teeth, and a delay in the maturation of specific membranous bones (Acampora et al., 1999; Depew et al., 1999) . Moreover, Dlx5 expression was induced orthotopically in mouse embryos treated with BMP proteins and in fractured bones of adult mice (Miyama et al., 1999) , and was up-regulated by BMPs and inhibited by Noggin, a BMP antagonist, in a calvarial explant culture system (Holleville et al., 2003) . These observations suggest that Dlx5 functions downstream of BMP signaling to regulate osteoblastic differentiation during organogenesis (Miyama et al., 1999) .
The homeobox gene Msx1 has been implicated in epithelial -mesenchymal interactions in vertebrate organogenesis (Davidson, 1995) . The Msx1 2/2 mice exhibit a number of craniofacial abnormalities including an arrest of tooth development at the bud stage. Associated with this arrest of tooth development is an absence of periodontal intramembranous bone, the alveolar process (Satokata and Maas, 1994) . It was demonstrated that a down-regulation of Bmp4 expression in the dental mesenchyme of Msx1 2/2 mice accounts for the down-regulation of several other genes and partially accounts for the arrest of tooth development (Chen et al., 1996; Zhang et al., 2000; Zhao et al., 2000) . Ectopic expression of Bmp4 driven by the mouse Msx1 promoter to the Msx1 2/2 dental mesenchyme was shown not only to restore downstream gene expression and partially rescue tooth development to the early cap stage, but also to rescue alveolar bone formation .
In this study, we further explore the role of BMP4 in the development of the alveolar bone. We confirm an indispensable role for BMP activity in the early tooth germ for the alveolar bone formation. A lack of Bmp4 expression in the dental mesenchyme in Msx1 2/2 embryos was found to be responsible for the down-regulation of Dlx5 and Cbfa1 expression in the early tooth germ, which leads to the absence of alveolar bone formation. Our results demonstrate that BMP4 mediates the function of Msx1 in controlling the development of the alveolar bone by regulating the expression of Dlx5 and Cbfa1.
Results

BMP activity is required for the formation of alveolar bone
In mice, the developmental process of alveolar bone formation begins at the early cap stage and involves mesenchymal condensation, osteoid deposition, and mineralization (Cho and Garant, 2000; Sodek and Mckee, 2000) . A well-defined intramembranous bony socket, consisting of differentiating osteoblasts that are enriched in bone matrix, is built surrounding the developing tooth at the early bell stage. Mice deficient in Msx1 exhibit an arrest of tooth development at the bud stage and an absence of alveolar bone (Satokata and Maas, 1994) . This arrest of tooth development in Msx1 2/2 embryo is accompanied by a dramatic down-regulation of Bmp4 expression in the dental mesenchyme (Chen et al., 1996) . We have previously reported the generation of transgenic mice harboring the human Bmp4 gene driven by the mouse Msx1 promoter . This promoter drives expression of the Bmp4 transgene in the dental mesenchyme, including the dental follicle, at the early cap stage, and in the developing alveolar bone at the bell stage . Ectopic expression of transgenic Bmp4 in Msx1 2/2 dental mesenchyme and alveolar bone rescued the formation of the alveolar process . These results suggest that BMP4 plays a vital role in mediating Msx1 function in regulating the development of alveolar bone.
To confirm that BMP activity in the developing tooth germ is required for the formation of the alveolar bone, we performed loss-of-function studies by inhibiting BMP activity using the BMP antagonist Noggin. Molar tooth germs from E13.5 wild type embryos were cultured in Trowell type organ cultures in the presence or absence of Noggin protein (100 ng/ml) for 48 h prior to being grafted for subrenal culture. Fifteen out of 16 control grafts (cultured in the absence of Noggin) developed welldifferentiated teeth and periodontal alveolar bone structures after 2-week subrenal culture (Fig. 1A) . In contrast, 11 out of 11 grafts treated with Noggin gave rise to keratinized cysts instead of tooth and periodontal bone structures (Fig. 1B) . Interestingly, six out of six molar tooth germs from E16.5 wild type embryos, similarly treated with Noggin prior to subrenal culture, produced teeth and intramembranous bone structures (Fig. 1C) . To further test if the lack of Bmp4 expression in dental mesenchyme of Msx1 mutants accounts for the absence of the alveolar bone, 
E13.5 molar tooth germs isolated from Msx1
2/2 embryos were implanted with beads soaked with BMP4 (100 ng/ml) or BSA, and cultured in Trowell type organ cultures for 24 h. Once the genotype was determined, each tooth germ with protein-soaked beads was grafted underneath the mouse kidney capsule and cultured for 2 weeks. In 12 out of 12 Msx1 2/2 molar germs implanted with BSA beads after subrenal culture, neither teeth nor bone structures were found after subrenal culture, but rather keratinized cysts formed in all these germs (Fig. 1D ). In contrast, 21 out of 24 Msx1 2/2 tooth germs implanted with BMP4-soaked beads showed well-differentiated intramembranous bone structures, although none contained a developing tooth (Fig. 1E ). This result contradicts the previous report by Bei et al. (2000) where the application of BMP4 to Msx1 2/2 tooth germs was able to fully rescue tooth development, but is consistent with our previous in vivo studies . As controls, application of BMP4 to wild type tooth germs did not affect tooth development and alveolar bone formation (Fig. 1F ). These results support our previous studies that demonstrated that ectopic BMP4 can bypass Msx1 function in the development of the alveolar bone and that the expression of Bmp4 in the dental mesenchyme is required for alveolar bone formation. Once the differentiation of alveolar bone begins at E16.5, BMP activity seems unnecessary for the continued development of alveolar bone structures.
2.2. Msx1 expression overlaps with that of Bmp4, Cbfa1, and Dlx5 in dental mesenchyme and developing alveolar bone, and is required for the expression of the latter genes During tooth development, the dental mesenchyme gives rise to the dental papilla and dental follicle that become distinguishable at the E14.5 cap stage. At the E16.5 early bell stage, the well-defined intramembranous bony socket of the alveolar process, which consists of differentiating osteoblasts, appears surrounding the developing tooth. The expression of Msx1 in developing teeth has been described previously (MacKenzie et al., 1991 (MacKenzie et al., , 1992 , and is found in the dental papilla and dental follicle ( Fig. 2A) and developing alveolar bone (Fig. 2B) . Bmp4, a known downstream target of Msx1 in dental mesenchyme, also exhibits an overlapping expression pattern in the dental papilla, as well as in the dental follicle and alveolar bone (Fig. 2C,D) . To address the molecular mechanism by which the Msx1/Bmp4 genetic pathway regulates alveolar bone development, we examined the expression of Cbfa1 and Dlx5, key regulators of osteoblast differentiation, in the dental follicle and alveolar bone of the developing tooth. In situ hybridization analysis revealed the expression of Cbfa1 and Dlx5 in both the dental papilla and dental follicle at E14.5 (Fig. 2E,G) . Dlx5 expression was also detected in the dental epithelium (Fig. 2G) . At the E16.5 early bell stage, Cbfa1 expression was downregulated in the dental papilla ( Fig. 2F ; De'Souza et al., 1999); but a high expression level was seen in the dental follicle and in the osteoblasts within the developing alveolar bone (Fig. 2F) . At the bell stage, Dlx5 expression was also detected in the developing alveolar bone, and a higher level of Dlx5 expression was observed in the dental papilla (Fig. 2H) . Thus, the expression of Cbfa1 and Dlx5 overlaps with that of Msx1 and Bmp4 in the dental follicle and alveolar bone during tooth development, implying that these genes might exist in the same genetic pathway regulating the development of the intramembranous bone that forms the alveolar process.
To place these genes within the genetic hierarchy that regulates alveolar bone formation, in situ hybridization was performed to examine the expression of Cbfa1 and Dlx5 in Msx1 2/2 tooth germ beginning at E13.5 when tooth development is arrested. Bmp4 expression was also examined in parallel. These analyses demonstrated that the expression of both Cbfa1 and Dlx5, similar to that of Bmp4 (data not shown), was down-regulated in the dental mesenchyme of Msx1 mutants at E13.5 (Fig. 3) . The expression of all three genes, Bmp4, Cbfa1, and Dlx5, was also undetectable in the Msx1 2/2 tooth germs at E14.5, E16.5, and E18.5 (data not shown), suggesting that Cbfa1 and Dlx5 reside downstream of Msx1 in developing teeth. This hypothesis was further supported by the finding that Msx1 expression remained unaltered in Cbfa1 2/2 dental mesenchyme (Fig. 4B) . Interestingly, Bmp4 also exhibited an unaltered expression pattern in the Cbfa1 2/2 dental mesenchyme (Fig.4D) . These results indicate that Msx1 functions upstream of Cbfa1 and Dlx5 in the dental mesenchyme and the expression of Cbfa1 and Dlx5 is dependent upon Msx1.
Ectopic expression of Bmp4 in Msx1
2/2 mutants rescues alveolar bone formation by activating Dlx5 and Cbfa1 expression It has been demonstrated that the down-regulation of Bmp4 expression in Msx1 2/2 dental mesenchyme accounts for the loss of expression of several other downstream genes, for the early arrest of tooth development, and for the absence of the alveolar process (Chen, et al., 1996; Zhang et al., 2000; Zhao et al., 2000) . To test whether the lack of Bmp4 expression in the Msx1 2/2 dental mesenchyme is also responsible for the failure of Cbfa1 and Dlx5 expression, we examined the expression of Cbfa1 and Dlx5 in the dental mesenchyme of Msx1 2/2 /Tg mice carrying the Bmp4 transgene (Msx1 2/2 /Tg). It was shown previously that the ectopic expression of a Bmp4 transgene in Msx1 2/2 dental mesenchyme restored the expression of Lef1 and Dlx2 . Therefore, Msx1 2/2 /Tg embryos ranging from E13.5 to E17.5, stages which correspond to the period when the rescued alveolar bone becomes differentiated, were analyzed for Cbfa1 and Dlx5 expression. The results showed that the expression of Cbfa1 remained absent in the dental mesenchyme of Msx1 2/2 /Tg embryos at E13.5 and E14.5 (Fig. 5A,B) . Bmp4 thus does (A-B) , Bmp4 (C-D), Cbfa1 (E-F), and Dlx5 (G-H) in the developing molar including the alveolar bone at E14.5 and E16.5. The expression of all these genes were detected in the dental papilla (DP), dental follicle (arrows in A, C, E, G), and alveolar bone (arrows in B, D, F, H). The dental epithelium is outlined with a dashed line. not function upstream of Cbfa1 in the dental mesenchyme. This conclusion is further supported by results from in vitro studies showing that BMP4 beads failed to induce Cbfa1 expression in the dental mesenchyme of both wild type and Msx1 2/2 mice ( Fig. 5D -F ; D'Souza et al., 1999) . The expression of Cbfa1 in the dental mesenchyme seems to be controlled by a distinct pathway regulated by Msx1. Interestingly, Cbfa1 expression was detected in the rescued differentiating alveolar process of E17.5 Msx1 2/2 /Tg embryos (Fig. 5C ), suggesting that BMP4 functions, either directly or indirectly, upstream of Cbfa1 in the development of the alveolar process. In contrast, the expression of Dlx5 was restored in the dental mesenchyme of Msx1 2/2 /Tg embryos at E13.5 and E14.5 (Fig. 5G,H) . This restored Dlx5 expression was detected in the rescued alveolar bone at E17.5 (Fig. 5I) . These results indicate that the downregulation of Bmp4 in the dental mesenchyme of Msx1 2/2 mutants is indeed responsible for the down-regulation of Dlx5 expression. Thus, Msx1 controls Dlx5 expression via Bmp4 in both the dental mesenchyme and alveolar bone. This conclusion is further supported by in vitro studies showing that Dlx5 expression was readily induced by BMP4-soaked beads in dental mesenchyme explants from both wild type and Msx1 mutants (Fig. 5J-L) .
The restored expression of Dlx5 and Cbfa1 is likely to regulate the differentiation and maturation of osteoblasts by activating the expression of osteoblast-specific genes in the rescued alveolar bone. Osteocalcin is a noncollagenous bone matrix protein that binds to calcium and regulates bone formation and mineralization. Its expression is known to be specifically regulated by Cbfa1 and Dlx5 (Ryoo et al., 1997; Zhang et al., 1997; Newberry et al., 1998; Miyama et al., 1999; Holleville et al., 2003) . Therefore, we examined the expression of Osteocalcin in the rescued alveolar bone of Msx1 2/2 /Tg mice. Osteocalcin expression was readily detected in the developing alveolar bone in wild type embryos at E17.5 (Fig. 5M) . As expected, the expression of Osteocalcin was absent in the molar region of Msx1 2/2 embryos at E17.5 due to the absence of the developing alveolar bone (Fig. 5N) . However, the expression of Fig. 3 . Msx1 is required for the expression of Cbfa1 and Dlx5 in the dental mesenchyme. (A, B) Cbfa1 expression was detected in molar mesenchyme (DM) of E13.5 wild type embryo (A), but was absent in dental mesenchyme of E13.5 Msx1 2/2 mutant (B). Note that the expression of Cbfa1 remained in the Meckel cartilage region of Msx1 2/2 mutant. (C, D) Dlx5 expression was found in both the dental epithelium and dental mesenchyme (DM) of E13.5 wild type molar tooth germ (C), but was undetectable in E13.5 Msx1 2/2 mutant dental mesenchyme (D). Note the unaltered Dlx5 expression in the dental epithelium of the Msx1 2/2 mutant. The dental epithelium is outlined with a dashed line.
Osteocalcin was indeed detected in the rescued alveolar process in Msx1 2/2 /Tg embryos at E17.5 (Fig. 5O ), indicating the presence of differentiated osteoblasts in the rescued alveolar bone. These results further support the idea that Cbfa1 and Dlx5 function downstream of the Msx1/Bmp4 in the genetic pathway that regulates osteoblast differentiation during the development of alveolar bone.
Discussion
Msx1 and Bmp4 have been shown to play vital roles in the initiation of tooth development (Vainio et al., 1993; Satokata and Maas, 1994; Chen et al., 1996; Zhang et al., 2000) . Additionally, these two genes are continuously expressed in the structures that derived from the dental mesenchyme including the dental follicle and the dental papilla throughout tooth development, suggesting an involvement of these genes in controlling the formation and differentiation of the dentition and the periodontal tissues.
The absence of the alveolar process in Msx1 2/2 mice demonstrates a requirement of Msx1 for the formation of this periodontal tissue. Our previous studies demonstrated that Bmp4 functions downstream of Msx1 to regulate early tooth development (Chen et al., 1996; Zhang et al., 2000) .
These current results further demonstrate that a downregulation of Bmp4 expression in Msx1 2/2 dental mesenchyme including region where the intramembranous alveolar bone forms accounts not only for the arrest of tooth development, but is also responsible for the absence of the alveolar bone. This conclusion is supported by in vitro and in vitro rescue studies in which exogenously applied BMP4 or transgenically expressed Bmp4 in the tooth germs of Msx1 2/2 embryo induced the formation of intramembranous periodontal bone in the absence of Msx1. However, similar to our previous in vivo transgenic studies , in our current studies, we failed to observe a complete rescue of tooth development by exogenous BMP4 protein in the Msx1 2/2 tooth germ grafts after subrenal culture, as reported by Bei and colleagues (Bei et al., 2000) . Variations in experimental procedures are not likely to explain the different results, because we followed the protocol described in the studies (Bei et al., 2000) . We also tried an alternative approach in which Msx1 2/2 tooth germs implanted with BMP4 beads were grafted via exo utero surgery into the diastema region of E13.5 host embryos, a site where control wild type tooth germ grafts were able to fully develop (data not shown). Once again cysts, but not teeth, formed in the Msx1 2/2 grafts (data not shown). Our previous studies demonstrated that BMP4 was able to rescue the expression of some, but not all genes in Msx1 2/2 tooth germs . We therefore believe that, although BMP4 is a critical factor, Msx1 controls the expression of additional molecules in the dental mesenchyme that are required for normal tooth development. Considering the role of BMP in bone formation, it is not surprising that abrogation of BMP activity by Noggin in early tooth germs led to the failure of the intramembranous bone formation. BMP4 may function to initiate osteogenic differentiation in the undifferentiated dental follicle, or act to regulate the differentiation of osteogenic cells in the developing alveolar bone. However, the constant presence of BMP activity seems not necessary for the formation of the alveolar process, as inhibition of BMP activity in the tooth germ at E16.5, when alveolar bone first begins to differentiate, did not affect alveolar bone formation.
Evidence has shown that Cbfa1 is critical for osteoblast differentiation (Ducy et al., 1997; Otto et al., 1997; Ducy, 2000 for review) . As a component of the periodontium, alveolar bone originates from the neural crest-derived dental mesenchyme, where the expression of Cbfa1 overlaps with that of Msx1 and Bmp4, suggesting that Cbfa1 may interact with or play a role in the Msx1/BMP4 genetic pathway that controls alveolar bone development. It was previously shown that the overexpression of Msx1 in an odontoblastic cell line inhibited Cbfa1 expression (Blin-Wakkach et al., 2001) . However, the fact that the expression of Cbfa1 is down-regulated in the dental mesenchyme of Msx1 2/2 mutants strongly argues that Msx1 is necessary for the normal expression of Cbfa1 in dental mesenchyme. The unaltered expression of Msx1 in Cbfa1 2/2 dental mesenchyme further places Cbfa1 downstream of Msx1 in the genetic hierarchy that regulates tooth development. These results are consistent with the observations that Msx1 mutants exhibit an earlier arrest of tooth development than Cbfa1 2/2 mice (Satokata and Maas, 1994; D'Souza et al., 1999) . Msx1 is known to control the expression of Bmp4 and Fgf3 in the dental mesenchyme; these factors are in turn responsible for the expression of a number of downstream genes (Chen et al., 1996; Bei and Maas, 1998; Zhang et al., 2000; Zhao et al., 2000) . Since BMP4 failed to induce Cbfa1 expression while FGFs stimulated Cbfa1 expression in the dental mesenchyme (D'Souza et al., 1999 ; this study), Msx1 likely regulates Cbfa1 expression via the FGF3 mediated signaling pathway in the dental mesenchyme of early developing teeth. In contrast, in the developing alveolar bone, BMP4 acts upstream to and regulates Cbfa1 expression, either directly or indirectly. This is evidenced by restored Cbfa1 expression in the rescued alveolar bone in Msx1 2/2 /Tg mice where Bmp4 was ectopically expressed in the developing alveolar bone. Here Cbfa1 may function to regulate osteoblast differentiation and maturation by activating the expression of osteoblast-specific genes such as Osteocalcin. Thus, the early events of alveolar bone development, such as the induction of the osteogenic lineage, are initiated and mediated by BMP signaling and are independent on the expression of Cbfa1.
During tooth development, Dlx5 expression was detected in the dental mesenchyme and its derivatives dental follicle and alveolar bone. The expression of Dlx5 in condensing and differentiating hard tissues, including cartilage, bone, and teeth, implies a role for Dlx5 in osterogenesis and chondrogenesis (Weiss, 1994 (Weiss, , 1995 Ferrari et al., 1995; Ryoo et al., 1997) . Our in vitro and in vivo results demonstrated that Dlx5 is one of the target genes induced by BMP4 signaling in the dental mesenchyme. This induction does not require functional Msx1 protein. Given the facts that the overexpression of Dlx5 enhances osteogenic differentiation in osteoblastic MC3T3-E1 cell lines and that Dlx5 2/2 mice exhibit abnormal alveolar bone formation (Depew et al., 1999; Miyama et al., 1999) , it appears that Dlx5 may be a component of the BMP4 signaling pathway in the induction of osteogenic development in the dental mesenchyme. This hypothesis is further supported by recent findings that Dlx5 functions as a part of the BMP signaling pathway that regulates calvarial development in early avian skull development (Holleville et al., 2003) . BMP2/4 signaling was shown to specifically regulate Dlx5 expression in proliferating preosteoblasts in the developing avian skull, implying that Dlx5 functions downstream of BMP signaling in regulating osteoblast differentiation (Holleville et al., 2003) . Several lines of evidence have implicated a role for Dlx5 in the regulation of Osteocalcin expression by counteracting with members of the Msx family (Ryoo et al., 1997; Zhang et al., 1997; Newberry et al., 1998; Blin-Wakkach et al., 2001; Shirakabe et al., 2001) . Thus the continuous expression of Dlx5 in differentiating osteoblasts in the alveolar bone may also participate in the regulation of Osteocalcin expression.
In summary, our studies demonstrate that Msx1 in dental mesenchyme controls the development of the tooth proper and the periodontal alveolar bone by regulating the expression of Bmp4, whose activity is required in the early tooth germ for the formation of periodontal bone structures. Ectopic expression of Bmp4 in the dental mesenchyme in the absence of Msx1 is able to initiate the induction of the osteogenic lineage, possibly by activating the expression of Dlx5. This induction of the osteogenic lineage apparently does not require Cbfa1. Activation of Cbfa1 by BMP4 in the developing alveolar bone may function together with Dlx5 to promote the differentiation of osteoblasts by regulating the expression of osteoblastspecific markers, such as Osteocalcin.
Materials and methods
Mice and mouse embryos collection
Msx1
2/2 mice, Msx1 2/2 mice carrying the Bmp4 transgene (Msx1 2/2 /Tg), and Cbfa1 2/2 mice used in this study have been described previously (Satokata and Maas, 1994; Otto et al., 1997; Zhang et al., 2000; Zhao et al., 2000) . These mice were outbreed onto a CD-1 background. Wild type mouse embryos used were of the CD-1 strain. The embryonic age was defined as E0.5 in the morning of the day when the vaginal plug was detected. The genotypes of Msx1 2/2 , Msx1 2/2 /Tg mice were determined by a polymerase chain reaction (PCR)-based method, and the genotype of Cbfa1 2/2 embryos was determined by Southern blot using a 1.5 kb Cbfa1 DNA fragment, as described previously (Chen et al., 1996; Otto et al., 1997; Zhang et al., 2000) . Genomic DNAs isolated from the tails of adult mice, or extraembryonic membranes or embryonic bodies were used for genotyping.
Histologic analysis
For histologic analysis of the developing alveolar process and tooth grafts after kidney capsule culture, embryonic heads ranging in age from E16.5 and to newborn, and tooth grafts after 2 weeks culture underneath the kidney capsule were collected in phosphate-buffered saline (PBS). Samples were fixed in 4% paraformaldehyde (PFA)/PBS overnight, dehydrated through a graded ethanol series, and processed for paraffin sectioning. Embryonic heads older than E17.5 and the tooth grafts were decalcified in 0.25 M EDTA (pH 5) in fixative for 2 days prior to being further processed. Azan red/Anilin blue dichromic staining was carried out as described (Presnell and Schreibman, 1997) .
In situ hybridization
Whole mount and section in situ hybridization was performed as described previously (St Amand et al., 2000) . For section in situ hybridization, serial paraffin sections were made at 10 mm. Nonradioactive riboprobes were labeled with Digoxigenin-UTP by in vitro transcription according to the manufacturer's instructions (Boehringer Mannheim, Indianapolis, IN). The following cDNAs were used to produce riboprobes: a 0.8-kb mouse Msx1 (Hill et al., 1989) ; a 1.0-kb mouse Bmp4 (Jones et al., 1991) ; a 1.0-kb mouse Osteocalcin (EST clone from Invitrogene); a 0.3-kb mouse Cbfa1; and a 0.9-kb mouse Dlx5 cDNA cloned by RT-PCR.
In vitro bead implantation
In vitro bead implantation was performed as described previously . Briefly, E13.5 molar tooth germs from wild type and Msx1 2/2 embryos were isolated in cold PBS. Dental epithelia were removed from the dental mesenchyme mechanically after enzyme treatment. Dental mesenchyme was placed on filters in Trowell type organ cultures. Affi-Gel blue agarose beads (Bio-Rad, Hercules, CA) were soaked in recombinant human BMP4 (100 mg/ml, from R&D Systems, Minneapolis, MN) or BSA (100 mg/ml) for 1 h at 37 8C prior to use. Protein-soaked beads were implanted onto the top of explants in DMEM culture medium supplemented with 10% fetal calf serum (FCS). Explants were harvested after 24 h in culture, fixed in 4% PFA and processed for whole mount in situ hybridization.
Kidney capsule grafting
Individual molar tooth germs were dissected from E13.5 wild type and Msx1 2/2 embryos, and placed on filters in Trowell type organ cultures. To inhibit BMP activity, Noggin protein (from R&D Systems, Minneapolis, MN) was added to DMEM culture medium (with 10% FCS) to a final concentration of 100 ng/ml, and the explants were cultured in vitro for 48 h prior to grafting. In the rescue experiments, BMP4 soaked beads (100 mg/ml) were implanted into tooth germs isolated from embryos obtained from Msx1 þ/2 matings. The genotype of each tooth germ was determined prior to grafting after 24 h in organ culture, each tooth germ with its implanted protein-soaked beads was grafted into the kidney capsule as described previously (Zhang et al., 2003) . Two weeks after grafting, host mice were sacrificed and the grafts were processed for histologic analysis.
